Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial
Top Cited Papers
- 1 October 2003
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 362 (9392), 1255-1260
- https://doi.org/10.1016/s0140-6736(03)14567-9
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Erythropoietin regulates tumour growth of human malignanciesCarcinogenesis: Integrative Cancer Research, 2003
- A Prognostic Score for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1998
- 452: Hemoglobin levels predict local regional control after postoperative radiotherapy for advanced head and neck cancerEuropean Journal Of Cancer, 1997
- Detection of erythropoietin in human liquor: Intrinsic erythropoietin production in the brainKidney International, 1997
- Chemotherapy Rapidly Alternating with Twice-a-Day Accelerated Radiation Therapy in Carcinomas Involving the Hypopharynx or Esophagus: An UpdateCancer Investigation, 1995
- Recombinant Human Erythropoietin Therapy for Anemic Cancer Patients on Combination ChemotherapyJNCI Journal of the National Cancer Institute, 1993
- The molecular mechanism of erythropoietin actionEuropean Journal of Biochemistry, 1992
- Phase I-II Trial of Erythropoietin in the Treatment of Cisplatin-Associated AnemiaJNCI Journal of the National Cancer Institute, 1992
- Erythropoietin Treatment of Anemia Associated with Multiple MyelomaNew England Journal of Medicine, 1990
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958